Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Morin

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Biological Psychiatry|June 1, 1979
Identification of dimethyltryptamine and O-methylbufotenin in human cerebrospinal fluid by combined gas chromatography/mass spectrometryJ R Smythies, R D Morin, G B Brown
Journal of Medicinal Chemistry|October 1, 1982
Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropaneR A Glennon, R Young, F Benington, et al.
Life Sciences|February 1, 1982
Hallucinogens as discriminative stimuli: a comparison of 4-OMe DMT and 5-OMe DMT with their methythio counterpartsR A Glennon, R Young, F Benington, et al.
Biochemical Medicine|October 1, 1975
Gas-liquid chromatographic separation and identification of biologically important indolealkylamines from human cerebrospinal fluidS T Christian, F Benington, R D Morin, et al.
Nature|May 16, 1970
Behavioural effects of some derivatives of amphetamine and LSD and their significanceJ R Smythies, J Beaton, F Benington, et al.
The Alabama Journal of Medical Sciences|January 1, 1977
A molecular mechanism of action of scorpion neurotoxinsJ R Smythies, F Benington, R J Bradley, et al.
Journal of Medicinal Chemistry|August 1, 1982
Structure-activity relationships in potentially hallucinogenic N,N-dialkyltryptamines substituted in the benzene moietyT B Kline, F Benington, R D Morin, et al.
European Journal of Pharmacology|February 1, 1972
The design of some new compounds to block psychotomimetic drugsJ R Smythies, J M Beaton, F Benington, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
2,4-Diamino-6-(bis-2-chloroethyl)aminomethyl pteridine. A new potent anticancer drugM A Khaled, R D Morin, F Benington, et al.
Experientia|August 15, 1975
Blockage of LSD binding at its high affinity site on synaptosomal membranes by 1-methyl-1,2,5,6-tetrahydropyridine-N,N-diethyl- carboxamideS T Christian, L D McClain, R D Morin, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Biological Psychiatry|June 1, 1979
Identification of dimethyltryptamine and O-methylbufotenin in human cerebrospinal fluid by combined gas chromatography/mass spectrometryJ R Smythies, R D Morin, G B Brown
Journal of Medicinal Chemistry|October 1, 1982
Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropaneR A Glennon, R Young, F Benington, et al.
Life Sciences|February 1, 1982
Hallucinogens as discriminative stimuli: a comparison of 4-OMe DMT and 5-OMe DMT with their methythio counterpartsR A Glennon, R Young, F Benington, et al.
Biochemical Medicine|October 1, 1975
Gas-liquid chromatographic separation and identification of biologically important indolealkylamines from human cerebrospinal fluidS T Christian, F Benington, R D Morin, et al.
Nature|May 16, 1970
Behavioural effects of some derivatives of amphetamine and LSD and their significanceJ R Smythies, J Beaton, F Benington, et al.
The Alabama Journal of Medical Sciences|January 1, 1977
A molecular mechanism of action of scorpion neurotoxinsJ R Smythies, F Benington, R J Bradley, et al.
Journal of Medicinal Chemistry|August 1, 1982
Structure-activity relationships in potentially hallucinogenic N,N-dialkyltryptamines substituted in the benzene moietyT B Kline, F Benington, R D Morin, et al.
European Journal of Pharmacology|February 1, 1972
The design of some new compounds to block psychotomimetic drugsJ R Smythies, J M Beaton, F Benington, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
2,4-Diamino-6-(bis-2-chloroethyl)aminomethyl pteridine. A new potent anticancer drugM A Khaled, R D Morin, F Benington, et al.
Experientia|August 15, 1975
Blockage of LSD binding at its high affinity site on synaptosomal membranes by 1-methyl-1,2,5,6-tetrahydropyridine-N,N-diethyl- carboxamideS T Christian, L D McClain, R D Morin, et al.
Pageof 4